FootPrints
Active Member
Posts: 254
Posted: Sat Jul 16, 2005 6:33 pm
Here are a few articles of interest:<br />
<br />
<b>Edda West from VRAN (Canada) on 5 in 1 vaccine (Pentacel)</b><br />
Good for the folks in the UK who are protesting the new 5 in 1 vaccine being foisted on them. Here in Canada, we didn't hear a peep in the media when Aventis Pasteur's 5 in 1 vaccine (Pentacel) was introduced across the board and injected into most Canadian babies starting in 1997.<br />
<br />
Although we can be grateful that thimerosal is no longer in the vaccine (except perhaps for trace amounts used in the manufacturing process which apparently they don't have to disclose), it has been replaced with 2-phenoxyethanol, a main ingredient in anti-freeze. You'd need to check the ingredients list to determine whether this is also being used in the U.K.version of the 5 in 1 vaccine. We've not been able to find any data showing that it is safe to inject infants with 2-phenoxyethanol or anti-freeze for that matter. Our understanding is that they were unable to continue using thimerosal, not because of safety concerns to babies, but because the inactivated polio viruses in Pentacel vaccine are altered by thimerosal, hence the need to switch to another preservative. Some sources state that 2-phenoxyethanol is a 'protoplasmic poison'. No matter how many vaccines your David Salisbury and Paul Offit in the U.S. think babies can handle, the bottom line is they are still being injected with toxic substances.<br />
<br />
Canadian infants have been the main test market for this vaccine these past 7 years, and based on this large experiment, Aventis is aiming to have it licensed for use in the U.S. either in 2004 or 05. Undoubtedly licensing in other countries is pending as well.<br />
<br />
Canada is the perfect test market for pharmaceutical companies testing new vaccines because:<br />
a) There is no mandatory reporting of vaccine reactions in this country, with the result that only a small fraction (between 1-10%) of adverse reactions are reported. <br />
<a href="http://www.whale.to/a/west5.html">continued</a><br />
<br />
<br />
<b>STATEMENT ON THIMEROSAL</b><br />
<br />
Introduction <br />
<br />
The National Advisory Committee on Immunization (NACI) has prepared this statement to provide recommendations on the use of vaccines licensed for use in Canada that contain the mercury-based preservative thimerosal, so that practitioners will have the information they need to make sound recommendations for vaccine administration to patients, and vaccine manufacturers will have guidance on the future development of vaccines for the Canadian market. The statement will also make recommendations on the management of patients who need vaccine that contains thimerosal but who report previous hypersensitivity to this constituent. <br />
<br />
Many vaccines licensed in Canada contain no thimerosal. Such vaccines are single-dose preparations in which thimerosal has not been used in any part of the manufacturing process. Other vaccines may contain trace amounts of thimerosal (
<br />
In Canada, the vaccines currently used in routine infant immunization do not contain thimerosal (see Table 1). Some hepatitis B vaccines licensed in Canada do, but one formulation with no thimerosal and another with only trace amounts are now available in Canada, and NACI recommends their use in infants preferentially. The two hepatitis B vaccines in which thimerosal is added as a preservative are gradually being phased out. Influenza vaccine also contains thimerosal but is only recommended for use in Canada for those infants > 6 months of age. The other vaccines licensed in Canada that contain thimerosal are primarily used for people travelling to developing countries and are not routinely administered to infants.<br />
<a href="http://www.cjmt.net/pages/699649/">continued</a><br />
<br />
<br />
<br />
<br />
<br />
These days, if you are not confused, you are not thinking clearly. Mrs. Irene Peters